Aralast alpha1-proteinase Inhibitor Surveillance Study

Clinical trial NCT00313144 · TERMINATED

Trial details

NCT number: NCT00313144
Sponsor: Baxalta now part of Shire
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Alpha1-antitrypsin Deficiency

Start date: 2006-06-09
Primary completion: 2008-12-01
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.